SOLID CANCER
Clinical trials for SOLID CANCER explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCER trials appear
Sign up with your email to follow new studies for SOLID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis early-stage study is testing a new drug called AK138D1 in people with advanced solid cancers that haven't responded to standard treatments. Researchers will give the drug to up to 200 participants to find the safest dose and see if it shows any signs of fighting their cancer…
Matched conditions: SOLID CANCER
Phase: PHASE1 • Sponsor: Akeso • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Can a natural compound make cancer treatment more powerful?
Disease control Recruiting nowThis study is testing whether a supplement called Urolithin A can improve how the immune system responds to cancer immunotherapy drugs. Researchers will compare 45 patients with newly diagnosed solid tumors who take either the supplement or a placebo while receiving standard immu…
Matched conditions: SOLID CANCER
Phase: NA • Sponsor: Goethe University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New cell therapy tested for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called TC-G203 for people with advanced solid tumors that have returned or spread. The main goal is to find the safest dose and see how well the body handles the treatment. It is for patients whose cancer has a specific marker …
Matched conditions: SOLID CANCER
Phase: EARLY_PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New hope for Tough-to-Treat ovarian cancer: trial tests 'Smart Bomb' drug
Disease control Recruiting nowThis study is testing a new drug called R-DXd for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to standard platinum-based chemotherapy. The drug is designed to target cancer cells specifically. The trial aims to find the be…
Matched conditions: SOLID CANCER
Phase: PHASE2, PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC
-
Fungus-Derived pill aims to rebuild cancer Patients' weakened immunity
Disease control Recruiting nowThis study is testing if a pill called PRaG-1 (cordycepin) can help restore a specific type of weakened immune cell in cancer survivors. It will involve about 127 adults who are free of solid tumors but have low CD8+ T-cell counts after finishing chemotherapy or radiation. Partic…
Matched conditions: SOLID CANCER
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC